BioForce Ebit Per Revenue from 2010 to 2025

Pink Sheets . USA . 
Stock . BioForce Nanosciences Holdings
BFNH Stock  USD 0.75  0.08  11.94%   
Check BioForce Nanosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioForce Nanosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . BioForce financial statements analysis is a perfect complement when working with BioForce Nanosciences Valuation or Volatility modules.
  
This module can also supplement various BioForce Nanosciences Technical models . Check out the analysis of BioForce Nanosciences Correlation against competitors.

Currently Active Assets on Macroaxis

SSentinelOne
CRMSalesforce
MSFTMicrosoft
GOOGAlphabet Inc Class C
GMGeneral Motors

Other Information on Investing in BioForce Pink Sheet

BioForce Nanosciences financial ratios help investors to determine whether BioForce Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioForce with respect to the benefits of owning BioForce Nanosciences security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY